Use of Hearing Aids Reduces Dementia Risk in Those With Hearing Loss
FRIDAY, April 14, 2023 (HealthDay News) — For people with hearing loss, use of hearing aids is associated with a reduction in the risk for dementia to a similar level to that of people without hearing loss, according to a study published online April…
Learn MoreDiagnosis of Difficult-to-Diagnose Developmental Disorders Discussed
FRIDAY, April 14, 2023 (HealthDay News) — Multimodal analysis of genome-wide data can diagnose probands with severe, probably monogenic, difficult-to-diagnose developmental disorders, according to a study published online April 12 in the New England …
Learn MoreAI Might Spot Alzheimer’s Early, Using Folks’ Speech Patterns
FRIDAY, April 14, 2023 (HealthDay News) — Cutting-edge AI technologies that can detect subtle changes in a person’s voice may help doctors diagnose Alzheimer’s disease and other cognitive impairments even before other symptoms begin.In a new study, r…
Learn MoreSmartphone-Aided Postoperative Monitoring Effective
THURSDAY, April 13, 2023 (HealthDay News) — Postoperative follow-up using smartphone app-assisted monitoring for patients undergoing breast reconstruction and gynecologic oncology surgery is associated with improved quality of recovery, according to …
Learn MoreHealth Highlights: April 13, 2023
Federal appeals court keeps abortion pill available temporarily. However, the ruling blocks getting mifepristone through the mail and rolls back other steps the government had taken to improve access. Read moreNew drug may treat rare diseases that mak…
Learn MoreGermline Genetic Testing Feasible for Advanced Prostate Cancer
WEDNESDAY, April 12, 2023 (HealthDay News) — Germline genetic testing followed by consultation with a genetic counselor is clinically impactful and yields high satisfaction for patients with advanced prostate cancer, according to a study published in…
Learn MoreInterferon Alfa-2b Effective for Low-Grade Lymphomatoid Granulomatosis
WEDNESDAY, April 12, 2023 (HealthDay News) — For low-grade lymphomatoid granulomatosis, interferon alfa-2b is efficacious, according to a study published online March 31 in The Lancet Haematology.Christopher Melani, M.D., from the National Institutes…
Learn MoreAI Offers Benefits for Initial Echocardiographic Assessment
WEDNESDAY, April 12, 2023 (HealthDay News) — For patients undergoing echocardiographic quantification of cardiac function, initial assessment of left ventricular ejection fraction (LVEF) by artificial intelligence (AI) is noninferior to assessment by…
Learn MoreDigital Cognitive Therapy Has Beneficial Effect for Patients With Insomnia
TUESDAY, April 11, 2023 (HealthDay News) — Digital cognitive behavioral therapy for insomnia (dCBT-I) is effective for patients with insomnia, with the optimal treatment including a combination of medication and dCBT-I, according to a study published…
Learn More¿Puede ChatGPT ofrecer consejos precisos sobre el cáncer de mama a las mujeres?
LUNES, 10 de abril de 2023 (HealthDay News) — ChatGPT, el chatbot de inteligencia artificial (IA) del que todo el mundo habla, puede con frecuencia ofrecer respuestas fiables a preguntas sobre el cáncer de mama, encuentra un estudio reciente. Pero to…
Learn More